Insider Holders & Insider Ownership - Aclaris Therapeutics Inc. (ACRS)

List of insiders holdings for Aclaris Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Leonard Braden Michael
10% Owner
2024-08-05 15:57:340
14,250,000
14,250,000Form 4
Foresite Capital Management III LLC
Foresite Capital Fund III L.P.
Foresite Capital Management IV LLC
Foresite Capital Fund IV L.P.
Foresite Capital Management V LLC
Foresite Capital Fund V L.P.
Tananbaum James B.
10% Owner
2022-02-11 15:12:534,657,277
0
4,657,277Form 13G
VIVO VENTURES VII LLC
Vivo Ventures Fund VII L.P.
Vivo Ventures VII Affiliates Fund L.P.
10% Owner
2019-02-14 15:35:521,647,214
0
1,647,214Form 13D
Sofinnova Venture Partners VIII L.P.
Sofinnova Management VIII L.L.C.
HEALY JAMES
AKKARAJU SRINIVAS
POWELL MICHAEL
10% Owner
2018-02-14 13:58:261,552,112
0
1,552,112Form 13D
Walker Neal
INTERIM PRESIDENT AND CEO
2024-10-03 16:15:091,435,909
0
1,435,909Form 4
Tullman Stephen A.
Director
2018-10-05 16:37:31177,457
394,014
571,471Form 4
Loerop James
Chief Business Officer
2024-02-05 19:29:48492,017
0
492,017Form 4
Powala Christopher
Chief Reg & Develop Officer
2019-02-05 18:33:25151,929
130,434
282,363Form 4
Monahan Joseph
Chief Scientific Officer
2024-03-05 17:04:56258,633
193
258,826Form 4
FMR LLC
See Remark 1
2020-02-07 11:12:21205,984
0
205,984Form 13G
Ruffo Frank
Chief Financial Officer
2022-03-14 16:56:19201,883
0
201,883Form 4
Ali-Jackson Kamil
Chief Legal Officer
2022-01-05 16:33:56160,214
0
160,214Form 4
Gordon David N.
Chief Medical Officer
2021-07-14 17:32:17147,447
0
147,447Form 4
Manion Douglas J.
Pres and CEO
2024-01-03 16:44:56122,813
0
122,813Form 4
Shanler Stuart
Chief Scientific Officer
2019-03-04 18:09:2682,200
0
82,200Form 4
Cawkwell Gail
Chief Medical Officer
2023-07-05 16:23:2554,593
0
54,593Form 4
Powell Andrew Kenneth William
Director
2024-06-04 16:30:2133,523
0
33,523Form 4
Reasons Bryan M.
Director
2024-06-04 16:30:2228,732
0
28,732Form 4
Balthaser Kevin
Chief Financial Officer
2024-09-04 19:52:5624,697
0
24,697Form 4
Fair Brett
Chief Commercial Officer
2019-02-05 18:30:0522,207
0
22,207Form 4
Mehra Anand
Director
2024-06-10 16:15:1120,543
0
20,543Form 4
SCHIFF ANDREW N
Director
2024-06-10 16:15:1420,543
0
20,543Form 4
GOWEN MAXINE
Director
2024-06-10 16:15:1620,543
0
20,543Form 4
Molineaux Christopher P.
Director
2024-06-10 16:15:1720,543
0
20,543Form 4
MILANO VINCENT
Director
2024-06-10 16:15:1820,543
0
20,543Form 4
Humphries William D.
Director
2024-06-10 16:15:2120,543
0
20,543Form 4
Bierly Rick
Director
2017-06-16 19:46:588,000
0
8,000Form 4
CHA ALBERT
Director
2016-07-01 16:17:176,632
0
6,632Form 4
Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Special Situations Fund L.P.
DEERFIELD PARTNERS L.P.
10% Owner
2020-02-13 12:36:570
0
0Form 13G
RA CAPITAL MANAGEMENT LLC
Kolchinsky Peter
RA Capital Healthcare Fund LP
10% Owner
2024-02-14 17:01:200
0
0Form 13G